The following London-listed shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
Credit Suisse cuts B&M European Value Retail price target to 370 (460) pence - ’neutral’
----------
HSBC raises B&M price target to 495 (480) pence - ’buy’
----------
RBC raises B&M price target to 400 (360) pence - ’sector perform’
----------
LBBW raises AstraZeneca price target to 12,000 (11,500) pence - ’buy’
----------
Stifel raises AstraZeneca price target to 13,300 (12,300) pence - ’buy’
----------
Shore Capital raises Informa to ’buy’ (hold)
----------
UBS raises Informa price target to 683 (654) pence - ’buy’
----------
Barclays raises Informa price target to 700 (685) pence - ’overweight’
----------
JPMorgan raises Informa price target to 650 (640) pence - ’neutral’
----------
Credit Suisse raises Informa price target to 740 (735) pence - ’outperform’
----------
Stifel raises GSK price target to 1,630 (1,600) pence - ’hold’
----------
RBC raises AB Foods price target to 1,600 (1,400) pence - ’sector perform’
----------
Liberum initiates Smith & Nephew with ’hold’ - target 1120 pence
----------
Liberum initiates ConvaTec with ’buy’ - target 265 pence
----------
FTSE 250
----------
Credit Suisse starts Hikma Pharmaceuticals with ’outperform’ - price target 1,700 pence
----------
JPMorgan raises Vesuvius price target to 425 (415) pence - ’neutral’
----------
RBC raises Marks & Spencer price target to 125 (105) pence - ’sector perform’
----------
RBC cuts Drax price target to 950 (1,175) pence - ’outperform’
----------
JPMorgan cuts Moonpig price target to 320 (460) pence - ’overweight’
----------
Jefferies cuts Aston Martin to ’underperform’ (hold) - price target 120 (530) pence
----------
SMALL CAP
----------
Credit Suisse raises S4 Capital price target to 295 pence - ’outperform’
----------
Citigroup cuts S4 Capital price target to 390 (415) pence - ’buy’
----------
HSBC cuts Nichols price target to 1,100 (1,220) pence - ’hold’
----------
Jefferies cuts ITM Power to ’hold’ (buy) - price target 105 (185) pence
----------
Liberum resumes Renewi with ’buy’ - target 865 pence
----------
Liberum initiates Advanced Medical Solutions with ’buy’ - target 339 pence
----------
Copyright 2022 Alliance News Limited. All Rights Reserved.
